Literature DB >> 3847402

A comparison of pneumonia caused by gentamicin, methicillin-resistant and gentamicin, methicillin-sensitive Staphylococcus aureus: epidemiologic and clinical studies.

J R Lentino, H Hennein, S Krause, S Pappas, G Fuller, D Schaaff, M B DiCostanzo.   

Abstract

We investigated an outbreak of nosocomial pneumonia due to gentamicin, methicillin-resistant Staphylococcus aureus (GMRSA). We compared the predisposing factors for pneumonia due to GMRSA to those for pneumonia due to gentamicin, methicillin-sensitive Staphylococcus aureus (GMSSA). Seventeen of 29 patients with staphylococcal pneumonia were infected with GMRSA. Risk factors and associated diseases which selected for infection with GMRSA as opposed to GMSSA included prior antibiotic therapy for a prolonged period of time (p = 0.0001), number of risk factors per patient (p = 0.0001), days hospitalized prior to diagnosis of pneumonia (p = 0.002) and number of associated diseases per patient (p = 0.002). Despite the epidemiologic differences between GMSSA and GMRSA pneumonia, there were no differences in the clinical presentation, course of illness, complications, response to appropriate therapy or outcome between the two groups. Survival was adversely affected by age only among the GMSSA patients (p = 0.02) and by the number of associated diseases (p = 0.005).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3847402     DOI: 10.1017/s0195941700061737

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  7 in total

1.  Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia.

Authors:  M Pujol; X Corbella; C Peña; R Pallares; J Dorca; R Verdaguer; A Diaz-Prieto; J Ariza; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

2.  Use of plasmid analysis and determination of aminoglycoside-modifying enzymes to characterize isolates from an outbreak of methicillin-resistant Staphylococcus aureus.

Authors:  C M Licitra; R G Brooks; P M Terry; K J Shaw; R S Hare
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

3.  Cell surface hydrophobicity and adherence to extra-cellular matrix proteins in two collections of methicillin-resistant Staphylococcus aureus.

Authors:  R G Cree; P Aleljung; M Paulsson; W Witte; W C Noble; A Ljungh; T Wadström
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

4.  Health care-associated Staphylococcus aureus pneumonia.

Authors:  Duncan Webster; Linda Chui; Gregory J Tyrrell; Thomas J Marrie
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-05       Impact factor: 2.471

5.  Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.

Authors:  J K Foster; J R Lentino; R Strodtman; C DiVincenzo
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

6.  Staphylococcus aureus Ventilator-Associated Pneumonia: A Study of Bacterio-Epidemiological Profile and Virulence Factors.

Authors:  Lamia Tilouche; Refka Ben Dhia; Sameh Boughattas; Soumaya Ketata; Olfa Bouallegue; Cherifa Chaouch; Noureddine Boujaafar
Journal:  Curr Microbiol       Date:  2021-05-10       Impact factor: 2.188

7.  No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.

Authors:  Josef Yayan; Beniam Ghebremedhin; Kurt Rasche
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.